Buprenorphine for the management of opioid withdrawal.

@article{Gowing2002BuprenorphineFT,
  title={Buprenorphine for the management of opioid withdrawal.},
  author={Linda R Gowing and Robert Ali and John L. White},
  journal={The Cochrane database of systematic reviews},
  year={2002},
  volume={2},
  pages={
          CD002025
        }
}
BACKGROUND Managed withdrawal (detoxification) is a necessary step prior to drug-free treatment. It may also represent the end point of long-term opioid replacement treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system. OBJECTIVES To assess the effectiveness of interventions involving the short-term use of buprenorphine to manage the acute phase of opioid withdrawal. SEARCH STRATEGY Multiple electronic databases were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 136 CITATIONS

Efficacy of buspirone in the treatment of opioid withdrawal.

  • Journal of clinical psychopharmacology
  • 2005
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Cebranopadol: novel dual opioid/NOP receptor agonist analgesic.

  • Journal of clinical pharmacy and therapeutics
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2001
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 6 Citations per year over the last 3 years

Similar Papers

Loading similar papers…